The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl (2R)-1-(4-{[5-(2-{[(4-Fluoro-3-methoxyphenyl)-methyl]carbamoyl}eth-1-yn-1-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl]methyl}benzoyl)pyrrolidine-2-carboxylate ID: ALA4062094
PubChem CID: 137636861
Max Phase: Preclinical
Molecular Formula: C29H27FN4O7
Molecular Weight: 562.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)[C@H]1CCCN1C(=O)c1ccc(Cn2cc(C#CC(=O)NCc3ccc(F)c(OC)c3)c(=O)[nH]c2=O)cc1
Standard InChI: InChI=1S/C29H27FN4O7/c1-40-24-14-19(7-11-22(24)30)15-31-25(35)12-10-21-17-33(29(39)32-26(21)36)16-18-5-8-20(9-6-18)27(37)34-13-3-4-23(34)28(38)41-2/h5-9,11,14,17,23H,3-4,13,15-16H2,1-2H3,(H,31,35)(H,32,36,39)/t23-/m1/s1
Standard InChI Key: BEOILPOZRLMAQX-HSZRJFAPSA-N
Molfile:
RDKit 2D
41 44 0 0 0 0 0 0 0 0999 V2000
22.8224 -23.2846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8224 -24.1149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5405 -24.5227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2483 -24.1149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2483 -23.2846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5405 -22.8663 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.9650 -24.5263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6815 -24.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1029 -22.8716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.9677 -22.8716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.4016 -25.3589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3980 -26.1850 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1169 -24.9479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8369 -25.3608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5563 -24.9540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2677 -25.3718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9822 -24.9619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9895 -24.1352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2692 -23.7171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5550 -24.1307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2714 -22.8931 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1127 -24.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3955 -24.1166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3967 -23.2968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6849 -22.8857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9695 -23.2986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9727 -24.1291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6896 -24.5345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2551 -22.8879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2535 -22.0638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9862 -22.4829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7055 -23.7272 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.5421 -23.3013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7918 -22.9705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2415 -23.5841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6550 -24.2970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4606 -24.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6183 -22.1650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8329 -21.9122 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.2298 -21.6112 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0561 -20.8047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
4 7 1 0
7 8 3 0
1 9 2 0
5 10 2 0
8 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
19 21 1 0
2 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
29 30 2 0
21 31 1 0
18 32 1 0
33 29 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 33 1 0
34 38 1 6
38 39 2 0
38 40 1 0
40 41 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 562.55Molecular Weight (Monoisotopic): 562.1864AlogP: 1.18#Rotatable Bonds: 7Polar Surface Area: 139.80Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.49CX Basic pKa: ┄CX LogP: 1.82CX LogD: 1.82Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.33Np Likeness Score: -1.10
References 1. Senn N, Ott M, Lanz J, Riedl R.. (2017) Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 Inhibitor., 60 (23): [PMID:28953404 ] [10.1021/acs.jmedchem.7b01001 ]